Cargando…
The EMT-activator ZEB1 induces bone metastasis associated genes including BMP-inhibitors
Tumor cell invasion, dissemination and metastasis is triggered by an aberrant activation of epithelial-to-mesenchymal transition (EMT), often mediated by the transcription factor ZEB1. Disseminating tumor cells must acquire specific features that allow them to colonize at different organ sites. Here...
Autores principales: | Mock, Kerstin, Preca, Bogdan-Tiberius, Brummer, Tilman, Brabletz, Simone, Stemmler, Marc P., Brabletz, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4546475/ https://www.ncbi.nlm.nih.gov/pubmed/25973542 |
Ejemplares similares
-
A novel ZEB1/HAS2 positive feedback loop promotes EMT in breast cancer
por: Preca, Bogdan-Tiberius, et al.
Publicado: (2017) -
ZEB1 turns into a transcriptional activator by interacting with YAP1 in aggressive cancer types
por: Lehmann, Waltraut, et al.
Publicado: (2016) -
ZEB1-associated drug resistance in cancer cells is reversed by the class I HDAC inhibitor mocetinostat
por: Meidhof, Simone, et al.
Publicado: (2015) -
Dynamic EMT: a multi‐tool for tumor progression
por: Brabletz, Simone, et al.
Publicado: (2021) -
Genome‐wide cooperation of EMT transcription factor ZEB1 with YAP and AP‐1 in breast cancer
por: Feldker, Nora, et al.
Publicado: (2020)